| Literature DB >> 20096520 |
Markus Nowak Lonsdale1, Thomas Beyer.
Abstract
Positron emission tomography (PET) has proven to be a clinically valuable imaging modality, particularly for oncology staging and therapy follow-up. The introduction of combined PET/CT imaging has helped address challenging imaging situations when anatomical information on PET-only was inadequate for accurate lesion localization. After a decade of PET/CT these combined systems have matured technically. Today, whole-body oncology staging is available with PET/CT in 15 min, or less. This review details recent developments in combined PET/CT instrumentation and points to implications for major applications in clinical oncology. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.Mesh：
Substances：
Year: 2010 PMID： 20096520 DOI： 10.1016/j.ejrad.2009.12.021
Source DB: PubMed Journal: Eur J Radiol ISSN： 0720-048X Impact factor: 3.528